Drugs / MB-JEV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01386827 Comparator | Jan 2008 → Apr 2011 | Japanese encephalitis | Helsinki University Central Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MBJEV | “The old mouse brain derived Japanese encephalitis vaccines (MBJEV) have been reported to cause serious adverse effects and are therefore replaced with the novel Ixiaro vaccine.” NCT01386827 ↗ |
| Known as | JE-MB | “traditional mouse brain-derived vaccines (JE-MB)” PMID 22696017 ↗ Jun 2012 |
| Modality | Vaccine | “traditional mouse brain-derived vaccines (JE-MB)” PMID 22696017 ↗ Jun 2012 |